Traws Pharma, Inc. - Director's Dealing 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-30

Reporting Person: Kumar Ramesh (Director, President and CEO)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-30	Common Stock	C	3748	—	Acquired	246696	Direct
2013-07-30	Common Stock	C	17424	—	Acquired	264120	Direct
2013-07-30	Common Stock	C	737	—	Acquired	264857	Direct
2013-07-30	Common Stock	C	1657	—	Acquired	266514	Direct
2013-07-30	Common Stock	C	811	—	Acquired	267325	Direct
2013-07-30	Common Stock	C	385	—	Acquired	267710	Direct
2013-07-30	Common Stock	C	573	—	Acquired	268283	Direct
2013-07-30	Common Stock	C	375	—	Acquired	268658	Direct
2013-07-30	Common Stock	C	75	—	Acquired	268733	Direct
2013-07-30	Common Stock	P	6667	$15.00	Acquired	275400	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Underlying	Ownership
2013-07-30	Series A Convertible Preferred Stock	$	C	4667	Disposed	Common Stock (3748)	Direct
2013-07-30	Series B Convertible Preferred Stock	$	C	20645	Disposed	Common Stock (17424)	Direct
2013-07-30	Series C Convertible Preferred Stock	$	C	983	Disposed	Common Stock (737)	Direct
2013-07-30	Series D Convertible Preferred Stock	$	C	2209	Disposed	Common Stock (1657)	Direct
2013-07-30	Series E Covertible Preferred Stock	$	C	1084	Disposed	Common Stock (811)	Direct
2013-07-30	Series F Convertible Preferred Stock	$	C	500	Disposed	Common Stock (385)	Direct
2013-07-30	Series G Convertible Preferred Stock	$	C	765	Disposed	Common Stock (573)	Direct
2013-07-30	Series H COnvertible Preferred Stock	$	C	500	Disposed	Common Stock (375)	Direct
2013-07-30	Series I Convertible Preferred Stock	$	C	100	Disposed	Common Stock (75)	Direct

F1: The Series A Convertible Preferred Stock converted into Common Stock on a 0.80-for-1 basis and had no expiration date.

F2: The Series B Convertible Preferred Stock converted into Common Stock on a 0.85-for-1 basis and had no expiration date.

F3: The Series C Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F4: The Series D Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F5: The Series E Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F6: The Series F Convertible Preferred Stock converted into Common Stock on a 0.77-for-1 basis and had no expiration date.

F7: The Series G Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F8: The Series H Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F9: The Series I Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.

F10: 150,037 shares are held indirectly by the Ramesh Kumar 2012 Trust, of which the reporting person is a trustee.